Phreesia, INC Form 4 insider transactions
NYSE
Form 4: Phreesia Inc. Executive Allison Hoffman Acquires Shares Through Employee Stock Purchase Plan
Allison Hoffman, General Counsel & Secretary of Phreesia Inc., reports the acquisition of 292 shares of common stock through the company's Employee Stock Purchase Plan at a price of $18.02 per share.
NYSE
Director Michael Weintraub reports acquisition of restricted stock units and indirect ownership of Phreesia, Inc. shares through trusts.
NYSE
Director Edward Cahill acquired 8,490 Restricted Stock Units (RSUs) in Phreesia, Inc., which will vest on June 26, 2025, or at the next annual meeting.
NYSE
Director Lisa Egbuonu-Davis reports acquiring 8,490 shares of Phreesia Inc. common stock through Restricted Stock Units (RSUs) and disposing of 19,539 shares on June 26, 2024.
NYSE
Director Lainie Goldstein acquired 8,490 Restricted Stock Units (RSUs) in Phreesia, Inc., which will vest upon the earlier of June 26, 2025, or the next annual meeting of stockholders, with deferred delivery of common stock.
NYSE
Director Gillian Munson reports the acquisition of 8,490 shares of Phreesia Inc. common stock through Restricted Stock Units (RSUs) as part of the company's 2019 Stock Option and Incentive Plan.
NYSE
Director Ramin Sayar acquired 8,490 shares of Phreesia, Inc. common stock on June 26, 2024, through the issuance of Restricted Stock Units (RSUs).
NYSE
Director Mark Douglas Smith acquired 8,490 Restricted Stock Units (RSUs) in Phreesia, Inc. on June 26, 2024, which will vest on the earlier of June 26, 2025, or the next annual meeting of stockholders.
NYSE
Form 4: Phreesia Inc. Principal Accounting Officer Janet Gunzburg Sells Shares to Cover Tax Obligations
Janet Gunzburg, Principal Accounting Officer of Phreesia Inc., sold 114 shares of common stock on June 21, 2024, to cover tax withholding obligations related to the settlement of restricted stock units.
NYSE
Form 4: Phreesia Inc. SVP, Life Sciences, David Linetsky, Reports Stock Sale to Cover Tax Obligations
David Linetsky, SVP of Life Sciences at Phreesia Inc., sold shares of common stock to cover tax withholding obligations related to the settlement of restricted stock units.
NYSE
David Linetsky, SVP at Phreesia, Inc., sold shares of common stock to cover tax withholding obligations related to the settlement of restricted stock units (RSUs).
NYSE
Form 4: Phreesia Inc. Principal Accounting Officer Janet Gunzburg Sells Shares to Cover Tax Obligations
Janet Gunzburg, Principal Accounting Officer of Phreesia Inc., sold 286 shares of common stock on May 1, 2024, to cover tax withholding obligations.
NYSE
Director Lainie Goldstein acquired 482 shares of Phreesia Inc. common stock on April 30, 2024, as part of a deferred compensation program.
NYSE
Director Gillian Munson acquired 482 shares of Phreesia Inc. common stock at $20.74 per share through deferred stock units.
NYSE
Director Edward Cahill increased his holdings in Phreesia through the acquisition of deferred stock units (DSUs) in lieu of a cash retainer.
NYSE
Form 4: Phreesia Inc. Principal Accounting Officer Janet Gunzburg Reports Sale of Shares for Tax Obligations
Janet Gunzburg, Principal Accounting Officer of Phreesia Inc., sold 912 shares of common stock on April 18, 2024, to cover tax withholding obligations related to the settlement of restricted stock units.
NYSE
David Linetsky, SVP of Life Sciences at Phreesia Inc., sold 269 shares of common stock on April 18, 2024, to cover tax withholding obligations related to the settlement of restricted stock units.
NYSE
Amy Beth VanDuyn, SVP of Human Resources at Phreesia Inc., sold 685 shares of common stock on April 15, 2024, to cover tax withholding obligations.
NYSE
David Linetsky, SVP of Life Sciences at Phreesia, Inc., sold 2,212 shares of common stock on April 15, 2024, to cover tax withholding obligations.
NYSE
Phreesia's Chief Operating Officer, Evan Roberts, disposed of 2,029 shares of common stock on April 15, 2024, to cover tax obligations related to the settlement of restricted stock units.
NYSE
Allison C. Hoffman, General Counsel & Secretary of Phreesia Inc., reports the sale of 1,238 shares of common stock on April 15, 2024, to cover tax obligations.
NYSE
Balaji Gandhi, CFO of Phreesia Inc., sold 948 shares of common stock on April 15, 2024, to cover tax withholding obligations related to the settlement of restricted stock units.
NYSE
Phreesia's CEO, Chaim Indig, disposed of 3,392 shares of common stock to cover tax withholding obligations related to the settlement of restricted stock units.
NYSE
Janet Gunzburg, Principal Accounting Officer of Phreesia Inc., sold 2,768 shares of common stock at a weighted average price of $23.0954 per share on April 10, 2024, under a pre-arranged 10b5-1 trading plan.
NYSE
Allison C. Hoffman, General Counsel & Secretary of Phreesia Inc., sold shares of common stock on April 8th and 9th, 2024, according to a Form 4 filing with the SEC.
NYSE
Balaji Gandhi, CFO of Phreesia, Inc., sold shares of common stock on April 8, 2024, to cover tax withholding obligations related to the settlement of restricted stock units.
NYSE
Phreesia's CEO, Chaim Indig, disposed of shares to cover tax withholding obligations related to the settlement of restricted stock units.
NYSE
Amy Beth VanDuyn, SVP of Human Resources at Phreesia, Inc., sold shares of common stock on April 8th and 9th, 2024, to cover tax obligations and under a pre-arranged 10b5-1 trading plan.
NYSE
Form 4: Phreesia Inc. COO Evan Roberts Executes Stock Option and Sells Shares to Cover Tax Obligations
Phreesia's Chief Operating Officer, Evan Roberts, exercised stock options and sold shares to cover tax obligations, as detailed in a recent SEC filing.
NYSE
David Linetsky, SVP of Life Sciences at Phreesia, Inc., sold shares of common stock to cover tax withholding obligations related to the settlement of restricted stock units.